A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cathine
Laniquidar
The serum concentration of Duvelisib can be increased when it is combined with Laniquidar.
Cathine
Rucaparib
The serum concentration of Duvelisib can be increased when it is combined with Rucaparib.
Cathine
Sarecycline
The serum concentration of Duvelisib can be increased when it is combined with Sarecycline.
Cathine
Voxilaprevir
The serum concentration of Duvelisib can be increased when it is combined with Voxilaprevir.
Cathine
Brefeldin A
The serum concentration of Duvelisib can be increased when it is combined with Brefeldin A.
Cathine
Pralsetinib
Pralsetinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Ripretinib
Ripretinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Letermovir
Letermovir may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Fedratinib
Fedratinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Nabiximols
Nabiximols may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Medical Cannabis
Medical Cannabis may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Estradiol valerate
Estradiol valerate may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Estradiol dienanthate
Estradiol dienanthate may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Estradiol cypionate
Estradiol cypionate may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Estradiol benzoate
Estradiol benzoate may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Estradiol acetate
Estradiol acetate may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Gilteritinib
Gilteritinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Fostamatinib
Fostamatinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Avatrombopag
Avatrombopag may decrease the excretion rate of Duvelisib which could result in a higher serum level.
Cathine
Glasdegib
Glasdegib may decrease the excretion rate of Duvelisib which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3